Page results
-
Our education department at the Royal London Hospital for Integrated Medicine, runs courses in integrated medicine for statutory registered health professionals.
-
The Integrated Children’s and Adolescent Service has been established to provide complementary care alongside orthodox treatments. The clinic sees children up to 18 years old with a wide variety of illnesses.
-
Information about the integrated general medicine service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated occupational therapy service at the Royal London Hospital for Integrated Medicine
-
Patient information by Respiratory Outpatient Physiotherapy regarding the treatment and management of your cough.
-
The Ataxia Centre brings together a team of specialists, with expertise in the diagnosis, management and research of all forms of ataxia.
-
This is a step-by-step guide on how to examine your testicles. It explains what you need to do and why it’s important. If you have any questions about the self-exam or information in this leaflet, speak to your nurse or doctor.
-
We offer comprehensive assessment, diagnostic services and investigation for all forms of the disease including neuropsychology, neurophysiology, imaging, genetic testing, and tissue diagnosis.
-
Advice on managing flare-ups and relapses for young people living with fatigue conditions.
-
The department specialises in the assessment and management of Complex Neuropsychiatric conditions occurring in the context of neurological disease.
File results
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications